Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic selection
Guidance in topic selection
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (1)
Technology type
Technology type
Device (56)
Diagnostic (16)
Medicine (128)
Procedure (145)
Topic selection decision
Topic selection decision
Awaiting decision (36)
Further information required (26)
Not selected (283)
Type
Type
Guidance (345)
Apply filters
Showing 51 to 100 of 345
Sort by
Decision date
Title
Apply sorting
Guidance in topic selection
Title
Technology type
Decision
Decision date
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]
Medicine
Not selected
4 February 2025
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]
Medicine
Not selected
4 February 2025
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]
Medicine
Not selected
4 February 2025
Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]
Medicine
Not selected
4 February 2025
Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]
Medicine
Not selected
4 February 2025
Lebrikizumab for treating atopic dermatitis in children [TSID12133]
Medicine
Not selected
4 February 2025
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496]
Medicine
Awaiting decision
28 January 2025
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy (review of TA673) [ID6403]
Medicine
Awaiting decision
21 January 2025
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]
Medicine
Awaiting decision
7 January 2025
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]
Medicine
Not selected
17 December 2024
NVK-002 for treating myopia in people 3 to 17 years [TSID11961]
Medicine
Not selected
12 December 2024
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353
Medicine
Not selected
9 December 2024
Transbronchial lung cryobiopsy
Procedure
Awaiting decision
27 November 2024
Noninvasive Vagus Nerve Stimulation For reactive airway disease
Procedure
Further information required
15 November 2024
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]
Medicine
Not selected
14 November 2024
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]
Medicine
Not selected
14 November 2024
Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]
Medicine
Awaiting decision
5 November 2024
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]
Medicine
Not selected
1 November 2024
Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085]
Medicine
Not selected
24 October 2024
Linaclotide acetate for treating Chronic idiopathic constipation [TSID12005]
Medicine
Not selected
10 September 2024
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]
Medicine
Not selected
10 September 2024
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]
Medicine
Not selected
10 September 2024
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]
Medicine
Not selected
10 September 2024
Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]
Medicine
Not selected
10 September 2024
Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia
Procedure
Further information required
21 August 2024
Budesonide–glycopyrronium–formoterol fumarate for treating severe asthma in people 12 years and over TS ID 12018
Medicine
Not selected
12 August 2024
Ferric maltol for treating iron deficiency anaemia in children and adolescents aged 1 month to 17 years TS ID 11994
Medicine
Not selected
19 July 2024
Human immunoglobulin with recombinant human hyaluronidase for maintenance treatment of multifocal motor neuropathy in people of any age TSID 12033
Medicine
Not selected
15 July 2024
Eszopiclone for treating insomnia [TSID12020]
Medicine
Not selected
11 July 2024
Aflibercept for untreated retinopathy in babies born preterm TS ID 11943
Medicine
Not selected
11 July 2024
Cefepime–enmetazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia TS ID 12035
Medicine
Not selected
4 July 2024
Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034
Medicine
Not selected
24 June 2024
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]
Medicine
Not selected
21 June 2024
IgPro20 for treating dermatomyositis [TSID12014]
Medicine
Not selected
13 June 2024
Basal insulin icodec–semaglutide for treating type 2 diabetes inadequately controlled with daily basal insulin [TSID11940]
Medicine
Not selected
6 June 2024
Subcutaneous nivolumab for treating advanced renal cell carcinoma after systemic treatment TSID 12008
Medicine
Not selected
6 June 2024
High linear energy transfer radiation for carbon ion beam therapy
Procedure
Further information required
30 May 2024
Letermovir for preventing cytomegalovirus infection in people under 18 years after allogeneic haematopoietic stem cell transplant [TS ID 11868]
Medicine
Not selected
28 May 2024
Mepolizumab for treating chronic obstructive pulmonary disease with eosinophil-associated exacerbations TSID12019
Medicine
Not selected
23 May 2024
Subcutaneous amivantamab for treating advanced non-small-cell lung cancer with EGFR mutations [TSID12011]
Medicine
Not selected
21 May 2024
Olorofim for treating invasive fungal infections in people 16 years and over [TSID11983]
Medicine
Not selected
18 April 2024
Vonicog alfa for preventing haemorrhage in people with von Willebrand disease when desmopressin is ineffective or not suitable [ID6272]
Medicine
Not selected
4 April 2024
Bismuth subcitrate potassium–metronidazole–tetracycline hydrochloride with omeprazole for treating Helicobacter pylori and preventing peptic ulcer relapse [TSID11900]
Medicine
Not selected
4 April 2024
Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years [TSID12002]
Medicine
Not selected
26 March 2024
Secukinumab biosimilar for treating plaque psoriasis [TSID11992]
Medicine
Not selected
21 March 2024
Transcatheter Tricuspid Valve Replacement
Procedure
Awaiting decision
13 March 2024
Radiofrequency denervation for OA shoulder pain
Procedure
Further information required
6 March 2024
Ciclosporin ophthalmic solution for treating dry eyes after inadequate response to artificial tears [TSID8472]
Medicine
Not selected
6 March 2024
Spinal instrumentation with robot assisted navigation
Procedure
Awaiting decision
5 March 2024
Neuromodulation for chronic pelvic pain
Procedure
Not selected
1 March 2024
Previous page
1
Current page
2
3
4
…
7
Page
2
of
7
Next page
Results per page
10
25
50
All
Back to top